FLUCONAZOLE TABLETS

The Defense Logistics Agency is soliciting 7 BT (each BT equals 3 units) of FLUCONAZOLE TABLETS, 100 MG, 30S, under NSN 6505-01-319-8248, with a delivery requirement of 20 days after award and FOB destination terms. The procurement is a Small Business Set-Aside under NAICS code 325412, issued as Request for Quotations SPE2DP-26-T-3562 with a submission deadline of June 2, 2026. The product must comply with FDA regulations and be packaged, marked, and labeled according to DLA’s Medical Marking Standard No. 1 and MIL-STD-129, with commercial packaging adhering to ASTM D3951 if non-hazardous or TQ requirement IP025 if hazardous. All units must have a non-extendable 24-month shelf life and be palletized per RP001. The contract requires full compliance with cybersecurity directives including safeguarding covered defense information, cyber incident reporting, and prohibition on acquiring certain telecommunications equipment, as outlined in multiple FAR and DFARS clauses such as 252.204-7012, 252.204-7018, and 52.240-93. Invoicing must be processed exclusively through WAWF with both invoice and receiving report submissions required unless exceptions apply, and contractors must be registered in SAM.gov with up-to-date representations and certifications, including small business status, combating trafficking in persons, employment eligibility verification, and equal opportunity for workers with disabilities. The Berry Amendment threshold of $150,000 applies, requiring disclosure of non-domestic material content. The contract further enforces whistleblower protections, restrictions on mandatory arbitration agreements, prohibitions on internal confidentiality agreements, and mandates compliance with federal, state, and local safety and hazardous material laws. All deliveries are subject to destination inspection under FAR 52.246-2, and any discrepancies must be reported via the DLA Customer Service portal.